NASDAQ: AQBAquabounty Technologies Inc Stock
$0.81-0.02 (-2.41%)
Updated Jun 13, 2025
AQB Price
$0.81
Fair Value Price
-$0.79
Market Cap
$3.14M
52 Week Low
$0.47
52 Week High
$1.94
P/E
-0.02x
P/B
0.18x
P/S
-5.58x
PEG
N/A
Dividend Yield
N/A
Revenue
-$477.27k
Earnings
-$137.63M
Gross Margin
-837.9%
Operating Margin
28,374.66%
Profit Margin
28,837.7%
Debt to Equity
0.73
Operating Cash Flow
-$12M
Beta
0.98
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AQB Overview
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AQB's potential to beat the market
- AQB doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Farm
Industry Rating
D
AQB
RankedUnranked of 13
RankedUnranked of 13
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $96.38 | B | |
| $32.82 | B | |
| $14.00 | C |
Be the first to know about important AQB news, forecast changes, insider trades & much more!
AQB News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AQB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AQB ($0.81) is overvalued by 202.63% relative to our estimate of its Fair Value price of -$0.79 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
AQB ($0.81) is not significantly undervalued (202.63%) relative to our estimate of its Fair Value price of -$0.79 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
AQB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AQB due diligence checks available for Premium users.
Valuation
AQB fair value
Fair Value of AQB stock based on Discounted Cash Flow (DCF)
Price
$0.81
Fair Value
-$0.79
Undervalued by
202.50%
AQB ($0.81) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AQB ($0.81) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AQB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
AQB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.02x
Industry
15.88x
Market
31.36x
AQB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.18x
Industry
1.12x
AQB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AQB's financial health
Profit margin
Revenue
$0.0
Net Income
$401.1k
Profit Margin
0%
AQB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AQB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$29.4M
Liabilities
$12.5M
Debt to equity
0.73
AQB's short-term liabilities ($12.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AQB's short-term assets ($6.72M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AQB's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
AQB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.4M
Investing
$3.7M
Financing
-$232.2k
AQB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
AQB vs Farm Stocks
Aquabounty Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.